Pharmaceuticals giant AstraZeneca launches Africa Health Innovation Hub to promote healthcare equity via AI, science and technology
AstraZeneca is teaming up with two African AI companies to boost healthcare via the Africa Health Innovation Hub.
This initiative highlights the pharmaceuticals giant’s commitment to healthcare equity and showcases the importance of partnerships with governments, healthcare providers, and patient advocacy groups.
The hub – one of 20 A. Catalyst Network hubs worldwide – aims to use artificial intelligence (AI) and easily-accessible apps to improve healthcare for patients in Africa.
“AstraZeneca aims to strengthen and future-proof health systems across the whole patient journey, ensuring everyone has equitable and affordable access to the life-changing healthcare solutions they need, regardless of where they live,” said Gagan Singh, Country President, African Cluster, AstraZeneca.
“The launch of the Africa Health Innovation Hub is a significant step in our goal to unlock digital transformation and innovation in health across the continent, paving the way for patient-centric, digital health solutions that leave no one behind.”
MedSol and Tricog team up with AstraZenica in Africa
AstraZeneca will partners with MedSol AI Solutions in South Africa and with Tricog Health in Kenya.
MedSol AI Solutions promotes early and accurate diagnosis of breast cancer while Tricog Health provides AI technology to provide remote cardiac diagnosis.
MeSol’s state-of-the-art Wi-Fi ultrasound probe can detect breast cancer in seconds. The Melusia app will be rolled out in rural clinics to help in early detection of the disease, supported by a dedicated referral system.
Read full article – https://bit.ly/4cZYcAJ
